Phase 3 results from the European clinical trial of the Palforzia peanut OIT treatment show that desensitization to the allergenic… Read more »
Desensitizing therapies are emerging for food allergies, and being considered for approval by the FDA. But some in the medical… Read more »
Almost half of youngsters could consume 10 times more peanut than at start of study.
In children, Viaskin Peanut built more allergen tolerance when used over two years.